Vida Ventures GP III, L.L.C. - 11 Jan 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
10%+ Owner
Signature
VIDA VENTURES GP III, L.L.C., By: /s/ Stefan Vitorovic, its Managing Member
Issuer symbol
VIGL
Transactions as of
11 Jan 2022
Net transactions value
+$23,450,000
Form type
4
Filing time
11 Jan 2022, 20:18:09 UTC
Previous filing
06 Jan 2022
Next filing
10 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIGL Common Stock Conversion of derivative security +3,333,245 3,333,245 11 Jan 2022 By Vida Ventures III, L.P. F1, F2
transaction VIGL Common Stock Conversion of derivative security +7,684 7,684 11 Jan 2022 By Vida Ventures III-A, L.P. F1, F3
transaction VIGL Common Stock Purchase $23,396,072 +1,671,148 +50% $14.00 5,004,393 11 Jan 2022 By Vida Ventures III, L.P. F2, F4
transaction VIGL Common Stock Purchase $53,928 +3,852 +50% $14.00 11,536 11 Jan 2022 By Vida Ventures III-A, L.P. F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Series B Preferred Stock Conversion of derivative security $0 -9,243,756 -100% $0.000000* 0 11 Jan 2022 Common Stock 3,333,245 By Vida Ventures III, L.P. F1, F2
transaction VIGL Series B Preferred Stock Conversion of derivative security $0 -21,310 -100% $0.000000* 0 11 Jan 2022 Common Stock 7,684 By Vida Ventures III-A, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
F2 The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C.("Vida III GP") is the general partner of Vida III. Vida III GP disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
F3 The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A. Vida III GP disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
F4 On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
F5 On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.